Bookmark

Add to MyYahoo RSS

GlaxoSmithKline News

News on GlaxoSmithKline (Ticker: GSK) continually updated from thousands of sources around the net.

7 hrs ago | Pharmaceutical Processing

Ligand Partner GlaxoSmithKline Receives FDA Approval for PromactaA /Revoladea

Ligand Pharmaceuticals Incorporated announced that its partner GlaxoSmithKline has received approval of a supplemental New Drug Application for the once-daily use of PromactaA /Revoladea in patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy .

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Ligand Pharmaceuticals

Tue Aug 26, 2014

Seeking Alpha

Novo Nordisk: The Case For Predictability In Earnings

Denmark is famous for producing bacon - lots of bacon. In fact, with a pig population of 18.9 million , there are more than three times as many pigs as there are people in Denmark, so there's plenty enough of the stuff to go around.

Comment?

Related Topix: Biotech, Novo Nordisk AS, Medicine, Healthcare Industry, Insulin (generic), Humulin, Novolin, Diabetes, Health, GlaxoSmithKline

Live Charts

Tuesday tips round-up: Royal Dutch Shell, Hyder Consulting, GSK

There is a lot to be said for value-based investment strategies as the year-to-date performance of The Daily Telegraph Questor column's six picks for 2014 show.

Comment?

Related Topix: Construction, Hyder Consulting, Biotech

Sys-Con Media

Genetic Technologies Announces Further Patent Success in USA

This action was initially brought by GTG against GSK in 2011, in the District Court of Colorado, but was then moved at the request of GSK to the District Court for the Middle District of North Carolina.

Comment?

Related Topix: Biotech, Genetic Technologies

Midwest InHouse

Mass. receives $2.1M in drug co. settlement

GlaxoSmithKline will pay Massachusetts $2.1 million to resolve allegations that it unlawfully promoted a popular asthma medication and two antidepressant drugs, Attorney General Martha Coakley announced.

Comment?

Related Topix: Biotech, Massachusetts, Massachusetts Government, Food and Drug Administration

Mon Aug 25, 2014

Investor's Business Daily

InterMune Stock Spikes On Rare Big Biotech Buyout

InterMune stock vaulted 36% on the stock market today , a day after the biotech company agreed to be bought by Roche for $8.3 billion.

Comment?

Related Topix: Biotech, Medicine, Pulmonary Medicine, Health, Fibrosis, Pulmozyme, Dornase Alfa (generic)

In-PharmaTechnologist.com

People on the Move at GSK, Allergan, Novartis

Westelinck was Executive Director and Global Head of Regulatory Affairs for Oncology at GlaxoSmithKline from 2010 to 2014.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

TheStreet.com

Why Jim Cramer Thinks Merck (MRK), Pfizer (PFE), GlaxoSmithKline...

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Pfizer, Biotech, Merck , Medicine, GlaxoSmithKline, Healthcare Industry, Mozilla

AmericanBankingNews.com

GlaxoSmithKline plc Receives Consensus Recommendation of "Hold" from Analysts

Shares of GlaxoSmithKline plc have received an average rating of "Hold" from the twenty analysts that are covering the stock, Analyst RN reports .

Comment?

Related Topix: Biotech, GlaxoSmithKline, Medicine, Healthcare Industry

Sys-Con Media

Clinical Trial Results, Change of Corporate Name, New Products, and...

Today, Analysts Review released its research reports regarding GlaxoSmithKline PLC , Amicus Therapeutics, Inc. , WellPoint Inc. , IDEXX Laboratories, Inc. and Endo International PLC .

Comment?

Related Topix: Wellpoint Health Networks, Insurance, Amicus, Startups, Biotech, Medicine, IDEXX Laboratories, Healthcare Industry, GlaxoSmithKline, Endo Pharmaceuticals Holdings

Sat Aug 23, 2014

The Star Online

What a pain

Dr Gopinathan Raju: ' Diagnosing and treating pain can be complex, as everyone experiences it differently, and their perception and experience of pain and pain tolerance is influenced by many factors.'

Comment?

Related Topix: Medicine, Health, Pain, Biotech, Southeast Asia, World News, Malaysia, Tylenol, Tempra, Acetaminophen (generic),

Fri Aug 22, 2014

AmericanBankingNews.com

GlaxoSmithKline plc Receives Hold Rating from Deutsche Bank

Shares of GlaxoSmithKline plc traded down 0.04% on Friday, hitting $47.68. 2,687,318 shares of the company's stock traded hands.

Comment?

Related Topix: Biotech, GlaxoSmithKline, Medicine, Healthcare Industry

ETaiwanNews.com

GlaxoSmithKline agrees to $105 million settlement

Under the settlement announced Wednesday, the London-based pharmaceutical also agreed to rules that bar it from paying doctors to promote its products; providing financial incentives that encourage salespeople to market s using results from inadequate studies or making unapproved claims that a product was "better, more effective, safer or has less ... (more)

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Sales, San Diego County, CA, Marketing

BioSpace

After Losing GlaxoSmithKline Deal, Pozen, Inc. Takes Another Step To No Longer Be A Drug Developer

Chapel Hill's Pozen completed a deal in which it ended a relationship with GlaxoSmithKline and took another step farther away from being a drug developer.

Comment?

Related Topix: Biotech, Medicine, Pozen, Healthcare Industry, GlaxoSmithKline, Research Triangle Park, NC

Thu Aug 21, 2014

Seeking Alpha

Theravance Biopharma: Neglected Spinoff Targeting A Huge Underserved Market

Theravance is probably a familiar name to many of you. The pharmaceutical company has received extensive coverage on Seeking Alpha over the years.

Comment?

Related Topix: Startups, Theravance, Copd, Medicine, Health, Biotech, GlaxoSmithKline, Healthcare Industry

HeraldSun.com

Rescue Mission's giveaway prepares kids for school

Essynce Boswell, 5, slides down an inflatable slide during the 15th annual Durham Rescue Mission back-to-school party on Thursday, August 21, 2014.

Comment?

Related Topix: Family, Kids, GlaxoSmithKline, Biotech, Medicine, Healthcare Industry, Hurricane, Weather, Hurricane Sandy, Durham, NC

JD Supra

What Can You Do When Risk Changes in a Third Party Relationship?

The GlaxoSmithKline PLC corruption matter in China continues to reverberate throughout the international business community, inside and outside China.

Comment?

Related Topix: Biotech, Privacy, US News

Seeking Alpha

Amgen Has Yet To Reach Its Potential, Despite Strong Gains

With shares of Amgen trading at near 52-week highs, investors are getting nervous about the next couple of quarters.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Johnson and Johnson, Pfizer

Business Journal

Analysts: Recent bouts of bad press could pose buying opportunity for GSK investors

It's been a bad few months for GlaxoSmithKline , the British based company with North American headquarters in Research Triangle Park.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Asthma, Health

Brand Republic

Wunderman wins global GSK pitch

GlaxoSmithKline is set to appoint Wunderman as the lead agency on its global digital advertising account after a pitch that began last year.

Comment?

Related Topix: Wunderman, Advertising, Biotech, GlaxoSmithKline, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••